These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 489544)

  • 21. Structure-function relationships of shortened [LeuB25]insulins, semisynthetic analogues of a mutant human insulin.
    Fischer WH; Saunders D; Brandenburg D; Diaconescu C; Wollmer A; Dodson G; De Meyts P; Zahn H
    Biol Chem Hoppe Seyler; 1986 Sep; 367(9):999-1006. PubMed ID: 3539147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemical synthesis of [des(tetrapeptide B27--30), Tyr(NH2)26-B] and [des(pentapeptide B26--30), Phe(NH2)25-B] bovine insulins.
    Cosmatos A; Ferderigos N; Katsoyannis PG
    Int J Pept Protein Res; 1979; 14(5):457-71. PubMed ID: 395118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radioimmunoassay of chemically modified insulins.
    Dron DI; Jones RH; Sönksen PH; Thomas JH; Brandenburg D
    Diabetologia; 1980 Jan; 18(1):59-63. PubMed ID: 6988266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nature of the B10 amino acid residue. Requirements for high biological activity of insulin.
    Burke GT; Schwartz G; Katsoyannis PG
    Int J Pept Protein Res; 1984 Apr; 23(4):394-401. PubMed ID: 6373642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Separation of the two double-chain bovine intermediates of the proinsulin-insulin conversion I. Chemical, immunochemical, circular dichroism, and biological characterization.
    Markussen J; Heding LG
    Int J Pept Protein Res; 1976; 8(6):597-606. PubMed ID: 992943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NA1, NA1, NA1-trimethylinsulin--an insulin analogue with a quaternary amino group at the A1 terminus.
    Drewes SE; Magojo HE; Gliemann J
    Hoppe Seylers Z Physiol Chem; 1981 Jun; 362(6):745-53. PubMed ID: 7024089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modification of arginines in bovine growth hormone.
    Wolfenstein-Todel C; Santomé JA
    Int J Pept Protein Res; 1983 Nov; 22(5):611-6. PubMed ID: 6317584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Insulin analogues with permuted A chain N-terminus (author's transl)].
    Krail G; Brandenburg D; Zahn H
    Hoppe Seylers Z Physiol Chem; 1975 Jun; 356(6):981-96. PubMed ID: 1181282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of des(tetrapeptide B(1-4)) and des(pentapeptide B(1-5)) human insulins. Two biologically active analogues.
    Schwartz G; Katsoyannis PG
    Biochemistry; 1978 Oct; 17(21):4550-6. PubMed ID: 718857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crystalline [A21-desamido]bovine insulin.
    Easter BR; Sutton DA; Drewes SE
    Hoppe Seylers Z Physiol Chem; 1978 Sep; 359(9):1229-36. PubMed ID: 711162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin analogues with modifications in the beta-turn of the B-chain.
    Wang SH; Hu SQ; Burke GT; Katsoyannis PG
    J Protein Chem; 1991 Jun; 10(3):313-24. PubMed ID: 1910463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and properties of carbonylbis(methionyl)insulin, a proinsulin analogue which is convertible to insulin by cyanogen bromide cleavage.
    Busse WD; Carpenter FH
    Biochemistry; 1976 Apr; 15(8):1649-57. PubMed ID: 5108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Soluble, prolonged-acting insulin derivatives. III. Degree of protraction, crystallizability and chemical stability of insulins substituted in positions A21, B13, B23, B27 and B30.
    Markussen J; Diers I; Hougaard P; Langkjaer L; Norris K; Snel L; Sørensen AR; Sørensen E; Voigt HO
    Protein Eng; 1988 Jul; 2(2):157-66. PubMed ID: 3072564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Partial synthesis and properties of des-A1-glycine-insulin (author's transl)].
    Brandenburg D; Biela M; Herbertz L; Zahn H
    Hoppe Seylers Z Physiol Chem; 1975 Jun; 356(6):961-79. PubMed ID: 1237459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Steric requirements at position B12 for high biological activity in insulin.
    Hu SQ; Burke GT; Schwartz GP; Ferderigos N; Ross JB; Katsoyannis PG
    Biochemistry; 1993 Mar; 32(10):2631-5. PubMed ID: 8448120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on the biological activity of degraded insulins and insulin fragments.
    Kikuchi K; Larner J; Freer RJ; Day AR; Morris H; Dell A
    J Biol Chem; 1980 Oct; 255(19):9281-8. PubMed ID: 6773963
    [No Abstract]   [Full Text] [Related]  

  • 37. Preparation and properties of citraconylinsulins.
    Naithani VK; Gattner HG
    Hoppe Seylers Z Physiol Chem; 1982 Dec; 363(12):1443-8. PubMed ID: 6761261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biological properties of chemically modified insulins. I. Biological activity of proinsulin and insulin modified at A1-glycine and B29-lysine.
    Jones RH; Dron DI; Ellis MJ; Sönksen PH; Brandenburg D
    Diabetologia; 1976 Dec; 12(6):601-8. PubMed ID: 1001848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective modification of tryptophan-149 in ovine pituitary lactogenic hormone.
    Kawauchi H; Bewley TA; Li CH
    Biochemistry; 1973 May; 12(11):2124-30. PubMed ID: 4705990
    [No Abstract]   [Full Text] [Related]  

  • 40. [B22-D-arginine]insulin: synthesis and biological properties.
    Knorr R; Danho W; Büllesbach EE; Gattner HG; Zahn H; King GL; Kahn CR
    Hoppe Seylers Z Physiol Chem; 1982 Dec; 363(12):1449-60. PubMed ID: 6761262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.